skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies

Journal Article · · Proceedings of the National Academy of Sciences of the United States of America
ORCiD logo [1];  [1];  [1];  [1];  [1];  [2];  [3];  [4];  [5];  [6];  [6];  [6];  [6];  [7];  [4];  [8];  [7]
  1. Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY 14853,
  2. Department of Microbiology, University of Iowa, Iowa City, IA 52242,
  3. Genetics Program, University of Iowa, Iowa City, IA 52242,
  4. Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712,, Department of Infectious Diseases, The University of Georgia College of Veterinary Medicine, Athens, GA 30602,
  5. Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853,
  6. Complex Carbohydrate Research Center, The University of Georgia, Athens, GA 30602
  7. Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY 14853,, Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY 14853,
  8. Department of Microbiology, University of Iowa, Iowa City, IA 52242,, Genetics Program, University of Iowa, Iowa City, IA 52242,

The O-antigen polysaccharide (O-PS) component of lipopolysaccharides on the surface of gram-negative bacteria is both a virulence factor and a B-cell antigen. Antibodies elicited by O-PS often confer protection against infection; therefore, O-PS glycoconjugate vaccines have proven useful against a number of different pathogenic bacteria. However, conventional methods for natural extraction or chemical synthesis of O-PS are technically demanding, inefficient, and expensive. In this paper, we describe an alternative methodology for producing glycoconjugate vaccines whereby recombinant O-PS biosynthesis is coordinated with vesiculation in laboratory strains of Escherichia coli to yield glycosylated outer membrane vesicles (glycOMVs) decorated with pathogen-mimetic glycotopes. Using this approach, glycOMVs corresponding to eight different pathogenic bacteria were generated. For example, expression of a 17-kb O-PS gene cluster from the highly virulent Francisella tularensis subsp. tularensis (type A) strain Schu S4 in hypervesiculating E. coli cells yielded glycOMVs that displayed F. tularensis O-PS. Immunization of BALB/c mice with glycOMVs elicited significant titers of O-PS–specific serum IgG antibodies as well as vaginal and bronchoalveolar IgA antibodies. Importantly, glycOMVs significantly prolonged survival upon subsequent challenge with F. tularensis Schu S4 and provided complete protection against challenge with two different F. tularensis subsp. holarctica (type B) live vaccine strains, thereby demonstrating the vaccine potential of glycOMVs. Finally, given the ease with which recombinant glycotopes can be expressed on OMVs, the strategy described here could be readily adapted for developing vaccines against many other bacterial pathogens.

Research Organization:
Univ. of Georgia, Athens, GA (United States); Cornell Univ., Ithaca, NY (United States)
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES); National Science Foundation (NSF); National Inst. of Health (NIH) (United States); New York State Office of Science, Technology and Academic Research (NYSTAR) (United States); US Army Research Office (ARO); Midwest Regional Center of Excellence (MRCE) for Biodefense and Emerging Infectious Disease Research (United States)
Contributing Organization:
Univ. of Iowa, Iowa City, IA (United States); Univ. of Texas, Austin, TX (United States)
Grant/Contract Number:
FG02-93ER20097; DMR-1120296; CBET 1159581; CBET 1264701; GM088905-01; EB005669-01; AI044642; AI057160; GM008629; AI064184; AI076322; GM10349010; W911NF-12-1-0390
OSTI ID:
1256136
Alternate ID(s):
OSTI ID: 1349046
Journal Information:
Proceedings of the National Academy of Sciences of the United States of America, Journal Name: Proceedings of the National Academy of Sciences of the United States of America Vol. 113 Journal Issue: 26; ISSN 0027-8424
Publisher:
Proceedings of the National Academy of SciencesCopyright Statement
Country of Publication:
United States
Language:
English
Citation Metrics:
Cited by: 90 works
Citation information provided by
Web of Science

References (62)

Purified Lipopolysaccharide from Francisella tularensis Live Vaccine Strain (LVS) Induces Protective Immunity against LVS Infection That Requires B Cells and Gamma Interferon journal April 2000
T Cell-Independent Antigens Type 2 journal April 1995
Exploitation of bacterial N -linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis journal May 2013
Biosynthesis and Assembly of Capsular Polysaccharides in Escherichia coli journal June 2006
γδ T Cells Provide an Early Source of Interferon γ in Tumor Immunity journal August 2003
Working toward the Future: Insights into Francisella tularensis Pathogenesis and Vaccine Development journal November 2009
Conjugate vaccines journal October 2003
Discovery of new biosynthetic pathways: the lipid A story journal October 2008
Incorporation of Heterologous Outer Membrane and Periplasmic Proteins into Escherichia coli Outer Membrane Vesicles journal October 2003
Biological Functions and Biogenesis of Secreted Bacterial Outer Membrane Vesicles journal October 2010
Recent developments in bacterial protein glycan coupling technology and glycoconjugate vaccine design journal April 2012
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis journal June 2009
Immunization with Salmonella enterica Serovar Typhimurium-Derived Outer Membrane Vesicles Delivering the Pneumococcal Protein PspA Confers Protection against Challenge with Streptococcus pneumoniae journal November 2010
Lipopolysaccharide Endotoxins journal June 2002
Elucidation of a novel Vibrio cholerae lipid A secondary hydroxy-acyltransferase and its role in innate immune recognition: Incorporation of hydroxy fatty acids into V. cholerae LPS by LpxN journal July 2011
Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis journal August 2001
Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae journal August 2008
Microbial biosynthesis of designer outer membrane vesicles journal October 2014
Expression cloning of Yersinia enterocolitica 0 : 3 rfb gene cluster in Escherichia coli K12 journal January 1991
Role of lipopolysaccharide and a major outer membrane protein from Francisella tularensis in the induction of immunity against tularemia journal January 1995
Characterization of the O antigen gene cluster and structural analysis of the O antigen of Francisella tularensis subsp. tularensis journal October 2003
Bexsero: A multicomponent vaccine for prevention of meningococcal disease journal February 2012
Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen journal January 2014
Preparation of bacterial polysaccharide–protein conjugates: Analytical and manufacturing challenges journal October 2009
Carbohydrate vaccines: developing sweet solutions to sticky situations? journal April 2010
Release of the type I secreted alpha-haemolysin via outer membrane vesicles from Escherichia coli journal January 2006
Vaccines based on the cell surface carbohydrates of pathogenic bacteria journal June 2005
T-cell–B-cell cooperation journal April 2004
Cognate Stimulatory B-Cell–T-Cell Interactions Are Critical for T-Cell Help Recruited by Glycoconjugate Vaccines journal December 1999
Naturally Produced Outer Membrane Vesicles from Pseudomonas aeruginosa Elicit a Potent Innate Immune Response via Combined Sensing of Both Lipopolysaccharide and Protein Components journal July 2010
Escherichia coli tol-pal Mutants Form Outer Membrane Vesicles journal September 1998
Immunology of bacterial polysaccharide antigens journal November 2003
Adjuvant properties of meningococcal outer membrane vesicles and the use of adjuvants in Neisseria meningitidis protein vaccines journal March 2011
Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro journal January 2013
Delivery of foreign antigens by engineered outer membrane vesicle vaccines journal January 2010
Protective B-cell epitopes of Francisella tularensis O-polysaccharide in a mouse model of respiratory tularaemia: Protective epitopes of Francisella tularensis O-antigen journal June 2012
Structure of the O-antigen of Francisella tularensis strain 15 journal July 1991
Modulating the innate immune response by combinatorial engineering of endotoxin journal January 2013
Identification, Characterization and Immunogenicity of an O-Antigen Capsular Polysaccharide of Francisella tularensis journal July 2010
B Cell Mitogenic Properties of Thymus-independent Antigens journal September 1973
Tularaemia: bioterrorism defence renews interest in Francisella tularensis journal December 2004
Production of glycoprotein vaccines in Escherichia coli journal January 2010
Production of Secretory and Extracellular N-Linked Glycoproteins in Escherichia coli journal December 2010
Characterization of bacteria using its O-antigen with surface-enhanced Raman scattering journal January 2010
Pathogenicity and molecular genetics of O-specific side-chain lipopolysaccharides of Escherichia coli journal July 1992
Immunologic Memory Induced by a Glycoconjugate Vaccine in a Murine Adoptive Lymphocyte Transfer Model journal May 1998
How Bacterial Carbohydrates Influence the Adaptive Immune System journal March 2010
Somatic antigens of Shigella: Structure of the O-specific polysaccharide chain of the Shigella dysenteriae type 7 lipopolysaccharide journal August 1988
A Novel Role for Plasmin-Mediated Degradation of Opsonizing Antibody in the Evasion of Host Immunity by Virulent, but Not Attenuated, Francisella tularensis journal September 2009
Engineering N-linked protein glycosylation with diverse O antigen lipopolysaccharide structures in Escherichia coli journal February 2005
Inactivated Francisella tularensis Live Vaccine Strain Protects against Respiratory Tularemia by Intranasal Vaccination in an Immunoglobulin A-Dependent Fashion journal February 2007
Innate B cell helpers reveal novel types of antibody responses journal January 2013
A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates journal January 1988
Mechanistic Insight into the TH1-Biased Immune Response to Recombinant Subunit Vaccines Delivered by Probiotic Bacteria-Derived Outer Membrane Vesicles journal November 2014
Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant journal August 2008
Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systems journal April 2006
Engineered Bacterial Outer Membrane Vesicles with Enhanced Functionality journal June 2008
Successful Protection against Tularemia in C57BL/6 Mice Is Correlated with Expansion of Francisella tularensis-Specific Effector T Cells journal November 2014
Membrane Vesicles Are Immunogenic Facsimiles of Salmonella typhimurium That Potently Activate Dendritic Cells, Prime B and T Cell Responses, and Stimulate Protective Immunity In Vivo journal November 2007
New vaccine platform? journal March 2010
Francisella tularensis Schu S4 Lipopolysaccharide Core Sugar and O-Antigen Mutants Are Attenuated in a Mouse Model of Tularemia journal January 2014
Expression of Heterologous Antigens in Commensal Neisseria spp.: Preservation of Conformational Epitopes with Vaccine Potential journal October 2004